Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
VRCA | Verrica Pharmaceuticals Inc. | Interim CFO | $133K | Nov 6, 2024 | ||
ACGN | Aceragen, Inc. | Chief Financial Officer | Jan 20, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|